Clark Kenneth A 4
4 · Summit Therapeutics Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Clark Kenneth A
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-02$9.18/sh+16,991$155,977→ 16,991 totalExercise: $18.35Exp: 2035-01-02→ Common Stock (16,991 underlying) - Award
Stock Option (right to buy)
2025-01-02+35,000→ 35,000 totalExercise: $18.35Exp: 2035-01-02→ Common Stock (35,000 underlying)
Footnotes (4)
- [F1]The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date.
- [F2]Not applicable.
- [F3]The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date.
- [F4]The option was issued to the reporting person pursuant to the issuers Director Retainer Option Election Plan in lieu of retainer fees of $155,900